Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2Phase 2 1

Status

Unknown 3Terminated 1Completed 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Sarcoma 2Other solid neoplasm 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Small Cell Lung Carcinoma 2Thymoma 1Testicular Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Neoplasm Metastasis 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Advanced Solid Tumors 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × isophosphamide mustard × Clear all
NCT01703754 2025-08-28

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.

Alaunos Therapeutics

Phase 2 Terminated
12 enrolled 24 charts
Breast

Breast Neoplasms

NCT01168791 2013-07-18

PICASSO III

Alaunos Therapeutics

Phase 3 Completed
447 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT01340547 2013-07-18

Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors

Alaunos Therapeutics

Phase 1 Unknown
24 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01555710 2013-05-21

Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)

Alaunos Therapeutics

Phase 3 Unknown
548 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01242072 2012-07-18

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Alaunos Therapeutics

Phase 1 Unknown
12 enrolled
GenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Osteosarcoma, Testicular Neoplasms, Thymoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡